‘Viread’ with KRW 65 billion and ‘Trajenta’ with KRW 58.3 billion… their unstoppable races

The Yuhan Corporation’s unstoppable race with its pharmaceutical products has caught everyone’s attention.

Its products have been in the center of attraction in the pharmaceutical market as the company recorded the third quarter collective sales worth of KRW 739.4 billion and a 9.8% increase compared to the last year, which leads to the first ‘KRW 1 trillion accomplishment’ in the Korean pharm...